To further investigate whether STAT3 inhibition was necessary for (−)-oleocanthal-induced suppression of HCC progression, HepG2 cells were treated with (−)-oleocanthal following transient transfection with constitutively active STAT3 (STAT3-C) (Figure 7C). This evidence concerns the gene STAT3 and hepatocellular carcinoma.